| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
General Counsel
1 company
Tang Carolyn C. is a General Counsel at Arcus Biosciences, Inc.. Recent SEC Form 4 filings include 0 buys and 16 sells.
Estimated insider holdings value: $3.2M based on current market prices.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Dec 17, 2025 | RCUS Arcus Biosciences, Inc. | General Counsel | Sell | 14,468 | $22.01 | $318,496.16 | -5.3% | +1.4% | - | |
| Dec 16, 2022 | RCUS Arcus Biosciences, Inc. | General Counsel | Sell | 2,523 | $30.75 | $77,582.04 | -4.2% | -45.1% | -41.3% | |
| Jun 17, 2022 | RCUS Arcus Biosciences, Inc. | General Counsel | Sell | 2,922 | $21.45 | $62,672.96 | -3.8% | +22.0% | -11.3% | |
| Dec 17, 2021 | RCUS Arcus Biosciences, Inc. | General Counsel | Sell | 1,109 | $40.12 | $44,496.61 | -1.0% | -17.1% | -25.7% | |
| Jun 17, 2021 | RCUS Arcus Biosciences, Inc. | General Counsel | Sell | 2,915 | $23.89 | $69,649.53 | -5.6% | +40.4% | -7.4% |